Literature DB >> 60779

Detection of beta2-microglobulin in sera from diverse vertebrate species by the use of a heterologous radioimmunoassay.

S M Gordon, T J Kindt.   

Abstract

The strong cross-reaction between rabbit and human beta2-microglobulins, as detected by goat antisera, has permitted the development of heterologous radioimmunoassays to detect homologues of beta2-microglobulin (beta2mu) in the sera of various vertebrate species. The assay based on the inhibition of the binding reaction between goat anti-rabbit beta2 mu and human beta2 mu divided the sera examined into two groups, one giving high levels of inhibition (approximately 80%). and the other lower levels (approximately 20%). There was no evident correlation between this division and phylogenetic classification. When the same group of sera was tested using the assay based on the inhibition of binding of rabbit beta2 mu to goat anti-human beta2 mu, a wide range of maximal levels of inhibition was observed, with clustering of phylogenetically related species.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60779     DOI: 10.1111/j.1365-3083.1976.tb00305.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Retinol-binding protein and beta 2-microglobulin in urine of cadmium-fed rhesus monkeys.

Authors:  K Nomiyama; M Yotoriyama; H Nomiyama
Journal:  Arch Environ Contam Toxicol       Date:  1981       Impact factor: 2.804

2.  Monoclonal antibodies as a tool for phylogenetic studies of major histocompatibility antigens and beta 2-microglobulin.

Authors:  J L Teillaud; D Crevat; P Chardon; J Kalil; C Goujet-Zalc; G Mahouy; M Vaiman; M Fellous; D Pious
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

3.  Identification of class I major histocompatibility complex encoded molecules in the amphibian Xenopus.

Authors:  M F Flajnik; J F Kaufman; P Riegert; L Du Pasquier
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.